Lung function at 6 and 18 months after preterm birth in relation to severity of bronchopulmonary dysplasia

Per Thunqvist1,2, Per Gustafsson3,4, Mikael Norman5

  • 1Sachs' Children's Hospital, Department of Pediatrics, Södersjukhuset, 118 83, Stockholm, Sweden.

Pediatric Pulmonology
|September 5, 2014
PubMed

Insights

Bronchopulmonary dysplasia (BPD) in preterm infants is linked to impaired lung function and respiratory symptoms. Respiratory morbidity in infancy is associated with reduced airway function and respiratory compliance, not initial BPD severity.

Area of Science:

  • Neonatology
  • Pediatric Pulmonology
  • Respiratory Medicine

Background:

  • Bronchopulmonary dysplasia (BPD) is a common complication in preterm infants, often leading to impaired lung function and respiratory symptoms.
  • The relationship between the initial severity of BPD, subsequent lung function, and respiratory morbidity requires further investigation.

Purpose of the Study:

  • To investigate the association between BPD severity and lung function in preterm infants.
  • To determine if impaired lung function is related to respiratory morbidity in this population.

Main Methods:

  • A longitudinal cohort study followed 55 preterm infants (23-30 weeks gestation) with mild or moderate/severe BPD.
  • Lung function was assessed at 6 and 18 months using passive lung mechanics and plethysmography.
  • Respiratory symptoms were recorded, and patient records were reviewed.

Main Results:

  • Most lung function measures were significantly below normative values at 18 months.
  • Moderate/severe BPD was associated with reduced respiratory system compliance (Cso) compared to mild BPD.
  • Infants with respiratory symptoms exhibited lower maximal forced expiratory flow and Cso.

Conclusions:

  • BPD severity did not predict overall lung function but may be linked to impaired alveolarization (reduced Cso).
  • Respiratory morbidity in infancy post-preterm birth is associated with reduced airway function and respiratory compliance.
Abstract

Related Concept Videos

Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
4.8K
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
29
Pulmonary Function Tests01:25

Pulmonary Function Tests

Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
1.1K
Atelectasis II: Pathophysiology01:10

Atelectasis II: Pathophysiology

Atelectasis develops when alveoli lose their air and collapse inward. Because lung tissue is naturally elastic, these air sacs shrink rather than remaining open. Collapsed alveoli are no longer ventilated, reducing their role in gas exchange. Blood flow may continue in these regions, creating a ventilation–perfusion mismatch. Clinical findings include decreased breath sounds, dullness to percussion, reduced chest expansion, and decreased tactile fremitus as sound transmission through...
25
Pneumothorax-II01:27

Pneumothorax-II

Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
1.7K
Factors Affecting Pulmonary Ventilation01:19

Factors Affecting Pulmonary Ventilation

Besides the pressure difference between the external environment and the lungs, the airflow rate and ease of pulmonary ventilation are also influenced by three other factors: surface tension of the fluid in the alveoli, compliance of the lungs, and airway resistance.
Alveolar Surface Tension
The alveolar fluid lines the luminal surface of the alveoli and exerts a force called surface tension. This force is caused by the polar water molecules in the liquid being more strongly attracted to each...
3.1K